Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 15, 2014 07:00 ET | Source: Cleveland BioLabs, Inc.

Cleveland BioLabs Announces Approval to Start Phase 1 Study for Hematopoietic Stem Cell Mobilizer CBLB612 in Russian Federation

BUFFALO, NY--(Marketwired - Sep 15, 2014) - Cleveland BioLabs, Inc. (NASDAQ: CBLI) today announced approval from the Ministry of Health of the Russian Federation to start a Phase 1 clinical trial...
September 08, 2014 07:00 ET | Source: Cleveland BioLabs, Inc.

Cleveland BioLabs and Sabby Announce Resolution of Litigation

BUFFALO, NY--(Marketwired - Sep 8, 2014) - Cleveland BioLabs, Inc. (NASDAQ: CBLI) and Sabby Healthcare Volatility Master Fund, Ltd. and Sabby Volatility Warrant Master Fund, Ltd. (collectively,...
September 03, 2014 07:00 ET | Source: Cleveland BioLabs, Inc.

Cleveland BioLabs Announces Green Light to Submit Pre-Emergency Use Authorization Application for Entolimod

BUFFALO, NY--(Marketwired - Sep 3, 2014) - Cleveland BioLabs, Inc. (NASDAQ: CBLI) today announced that the minutes from its meeting with the U.S. Food and Drug Administration (FDA) in July confirmed...
September 02, 2014 16:30 ET | Source: Cleveland BioLabs, Inc.

Cleveland BioLabs to Report Outcome of July FDA Meeting and Host Conference Call on September 3

BUFFALO, NY--(Marketwired - Sep 2, 2014) - Cleveland BioLabs, Inc. (NASDAQ: CBLI) today announced that on September 3, 2014, it will report the outcome of the Company's July meeting with the U.S....
September 02, 2014 09:00 ET | Source: Cleveland BioLabs, Inc.

Cleveland BioLabs to Present at Rodman & Renshaw 16th Annual Global Investment Conference

BUFFALO, NY--(Marketwired - Sep 2, 2014) - Cleveland BioLabs, Inc. (NASDAQ: CBLI) today announced that the Company is scheduled to present at the Rodman & Renshaw 16th Annual Global Investment...
August 07, 2014 07:00 ET | Source: Cleveland BioLabs, Inc.

Cleveland BioLabs Reports Second Quarter 2014 Financial Results and Development Progress

BUFFALO, NY--(Marketwired - Aug 7, 2014) - Cleveland BioLabs, Inc. (NASDAQ: CBLI) today reported financial results and development progress for the second quarter ended June 30, 2014. ...
July 29, 2014 08:00 ET | Source: Cleveland BioLabs, Inc.

Cleveland BioLabs to Report Second Quarter 2014 Financial Results and Provide Operational Update on August 7

BUFFALO, NY--(Marketwired - Jul 29, 2014) - Cleveland BioLabs, Inc. (NASDAQ: CBLI) today announced that on August 7, 2014, it will report its financial results for the second quarter ended June 30,...
June 18, 2014 09:25 ET | Source: Cleveland BioLabs, Inc.

Cleveland BioLabs Reduces Debt With $3.5 Million At-the-Market Private Placement of Unregistered Stock

BUFFALO, NY--(Marketwired - Jun 18, 2014) - Cleveland BioLabs, Inc. (NASDAQ: CBLI) today announced that it entered into a securities purchase agreement (the "Purchase Agreement") with Dr. Mikhail...
May 09, 2014 08:00 ET | Source: Cleveland BioLabs, Inc.

Cleveland BioLabs Announces Compensation Reductions for Co-Founders and Directors; New Board Nominees

BUFFALO, NY--(Marketwired - May 9, 2014) - Cleveland BioLabs, Inc. (NASDAQ: CBLI) today announced that two of the Company's co-founders, Chief Executive Officer, Yakov Kogan and Chief Scientific...
May 08, 2014 07:30 ET | Source: Cleveland BioLabs, Inc.

Cleveland BioLabs Reports First Quarter 2014 Financial Results and Development Progress

BUFFALO, NY--(Marketwired - May 8, 2014) - Cleveland BioLabs, Inc. (NASDAQ: CBLI) today reported financial results and development progress for the first quarter ended March 31, 2014. ...